Skip to main content
. 2014 May 31;18(2):48–51. doi: 10.14701/kjhbps.2014.18.2.48

Table 1.

The target trough levels of tacrolimus with and without mycophenolate mofetil (MMF) relative to the posttransplant period after adult living-donor liver transplantation. The values of calcineurin inhibitor (CNI)-sparing tacrolimus are comparable to the suggested CNI target levels for hepatocellular carcinoma patients beyond the Milan criteria

graphic file with name kjhbps-18-48-i001.jpg